Farther Finance Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Sell |
1,522
-142
| -9% | -$3.08K | ﹤0.01% | 2352 |
|
|
2025
Q1 | $39.8K | Sell |
1,664
-1,026
| -38% | -$24.5K | ﹤0.01% | 2008 |
|
|
2024
Q4 | $56.1K | Buy |
2,690
+1,495
| +125% | +$31.2K | ﹤0.01% | 1600 |
|
|
2024
Q3 | $23.8K | Buy |
1,195
+713
| +148% | +$14.2K | ﹤0.01% | 2001 |
|
|
2024
Q2 | $7.6K | Buy |
482
+70
| +17% | +$1.1K | ﹤0.01% | 2188 |
|
|
2024
Q1 | $6.49K | Buy |
412
+9
| +2% | +$142 | ﹤0.01% | 1947 |
|
|
2023
Q4 | $6.77K | Sell |
403
-165
| -29% | -$2.77K | ﹤0.01% | 1816 |
|
|
2023
Q3 | $6.64K | Hold |
568
| – | – | ﹤0.01% | 1422 |
|
|
2023
Q2 | $7.63K | Hold |
568
| – | – | ﹤0.01% | 1281 |
|
|
2023
Q1 | $9.42K | Hold |
568
| – | – | ﹤0.01% | 1137 |
|
|
2022
Q4 | $10.6K | Buy |
+568
| New | +$10.6K | ﹤0.01% | 929 |
|